LONDON -- When weighing up a potential investment, it's useful to look forward rather than backward. If you buy a stake in a business, it's the future profits that count -- and the stock market will value your shares based on future expectations.
With that in mind, it can be helpful to review what expert City analysts are expecting a company to earn in the coming years. These expectations can be compared to the share price, to give you a better idea of how the stock market is valuing the business.
Today, I'm looking at the earnings per share (EPS) forecasts for�Tesco� (LSE: TSCO ) (NASDAQOTH: TSCDY ) , the FTSE 100 supermarket giant. All my figures are courtesy of S&P Capital IQ.
Analysts expect Tesco to earn 33 pence per share this year. Compared to today's share price of 380 pence, the market is valuing Tesco's shares on a forward price-to-earnings multiple of 11.5.
However, analysts are far from agreed on this year's estimates, with different experts forecasting earnings per share ranging widely between 21 pence, and 38 pence.
Top Supermarket Stocks To Watch Right Now: Uralkaliy OAO (URALL.PK)
Uralkaliy OAO (Uralkali OJSC) is a Russia-based company, which is engaged in the chemical industry. The Company specializes in the production of potash fertilizers. Its product portfolio comprises pink muriate of potash (PMOP), white muriate of potash (WMOP) and granular (GMOP). The Company is active through representative offices, located in Moscow and Beijing, as well as numerous subsidiaries, located countrywide and in Panama, Belarus, Singapore, Brazil and others. Uralkaliy OAO operates on the potassium and magnesium deposits located in Berezniki, Perm and Saint Petersburg. Its production assets include seven plants and five mines. Uralkaliy OAO sells its products domestically, as well as abroad in over 40 countries, including the United States, China, Brazil, India and South-East Asia, among others. Advisors' Opinion:- [By Chris Damas]
This morning Russian potash giant OJSC Uralkali (URALL.PK) presented first half 2013 financial and operating results and more importantly, much anticipated comments on the strategy of the company and the state of the international potash industry, the latter blind-sided by the leading potash company's split with marketing partner JSC Belaruskali of Belarus.
- [By Tim Gallagher]
The potash spat continues to get uglier, as Belarus investigators reportedly intend to seize property and assets of Russia's Uralkali (URALL.PK) following the collapse of the joint Russian-Belarussian potash venture.
Top Supermarket Stocks To Watch Right Now: Solitario Exploration & Royalty Corp (XPL)
Solitario Exploration & Royalty Corp. is an exploration company. The Company is a gold producer with its development-stage Mt.Hamilton gold project in Nevada. The Company has a portfolio of royalty structured joint ventures on advanced mineral projects with partners, such as Votorantim Metais, Anglo Platinum and Newmont Mining. The Company�� advanced projects include Mt. Hamilton: gold project, the United States, Bongara: zinc-lead-silver, Peru, and Pedra Branca: platinum-palladium, Brazil. Its gold-silver exploration projects include Pachuca Real: silver-gold, Mexico and Cerro Azul: Gold-Silver, Peru. The Company�� base metal and polymetallic exploration projects include Chambara: zinc-lead-silver, Peru and La Promesa: silver-zinc-lead-indium, Peru. In December 2013, Solitario Exploration & Royalty Corp raised its interest to 23.537% from 3.233%, by acquiring a 20.304% stake in Ely Gold & Minerals Inc. Advisors' Opinion:- [By Monica Wolfe]
Solitario Exploration & Royalty (XPL)
Several insiders made significant buys this week as the company�� share price continues to dwindle beneath its all-time lows. Most notably, President and CEO Christopher Herald bought 400,000 shares. He purchased these shares at $0.84 per share for a total transaction amount of $336,000. Since this buy, the share price has increased approximately 11.9%.
Hot Food Companies To Own For 2015: Primo Water Corporation(PRMW)
Primo Water Corporation, together with its subsidiaries, provides three- and five-gallon purified bottled water, self-serve filtered drinking water, water dispensers, and carbonating beverage appliances in the United States and Canada. The company?s Primo Water segment sells multi-gallon purified bottled water and self-serve filtered drinking water vending service through retailers in the United States and Canada. It offers its services through point of purchase display racks or self-serve filtered water vending displays, and recycling centers. Its Primo Dispensers segment sells water dispensers that are designed to dispense Primo and other dispenser-compatible bottled water. This segment engages in dispensers sales primarily through retailers. The company also offers home beverage appliances, flavor concentrates, carbon dioxide cylinders, and accessories used with the appliances to make various cold beverages. As of December 31, 2011, its exchange and refill services wer e offered in each of the contiguous United States and in Canada at approximately 23,600 combined retail locations. Primo Water Corporation was founded in 2004 and is headquartered in Winston-Salem, North Carolina.
Advisors' Opinion:- [By Bryan Murphy]
Look out Primo Water Corporation (NASDAQ:PRMW), there's a serious threat nipping out your heels, and there way of "doing bottled water" may be a heck of a lot easier for consumers to swallow than your way. The name of that budding competition? Alkaline Water Company Inc. (OTCBB:WTER). In fact, WTER became just a little more competitive on Tuesday thanks to widening its reach.... again.
- [By Roberto Pedone]
Primo Water (PRMW) is a provider of multi-gallon purified bottled water, self-serve filtered drinking water, water dispensers and carbonating beverage appliances sold through major retailers in the U.S. and Canada. This stock closed up 9.6% to $2.16 in Thursday's trading session.
Thursday's Range: $1.97-$2.20
52-Week Range: $0.69-$2.20
Thursday's Volume: 329,000
Three-Month Average Volume: 145,397From a technical perspective, PRMW ripped higher here right above some near-term support at $1.85 with heavy upside volume. This stock broke out above some near-term overhead resistance at $2.14 and into new 52-week-high territory, which is bullish technical price action.
Traders should now look for long-biased trades in PRMW as long as it's trending Thursday's low of $1.97 and then once it sustains a move or close above its new 52-week high at $2.20 and above some past resistance at $2.28 with volume that hits near or above 145,397 shares. If we get that move soon, then PRMW will set up to enter new 52-week-high territory, which is bullish price action. Some possible upside targets off that move are its next major overhead resistance levels at $3 to $3.11.
Top Supermarket Stocks To Watch Right Now: Saratoga Investment Corp(SAR)
Saratoga Investment Corp. is a business development company specializing in buyout, acquisition, growth, recapitalization, and note financing transactions of private middle market companies. It structures its investments as debt and equity by investing through first and second lien loans, mezzanine debt, select high yield bonds, senior secured bonds, unsecured bonds, and preferred and common equity. It seeks to invest in the United States. The firm primarily invests in companies having EBITDA between $5 million and $50 million. It invests through direct lending as well as participation in loan syndicates. The firm was formerly known as GSC Investment Corp. Saratoga Investment Corp. is based in New York, New York with an additional office in Florham Park, New Jersey.
Advisors' Opinion:- [By Laura Brodbeck]
Monday
Earnings Releases Expected: Citigroup Inc. (NYSE: C), Saratoga Investment Corp. (NYSE: SAR), Bank of the Ozarks (NASDAQ: OZRK) Economic Releases Expected: Japanese industrial production, eurozone industrial productionTuesday
Top Supermarket Stocks To Watch Right Now: Lucara Diamond Corp (LUCRF.PK)
Lucara Diamond Corp. (Lucara) is a diamond development company focused in Africa. The business of Lucara consists of the acquisition, exploration and development of diamond properties. The principal assets of Lucara and the focus of Lucara�� development and exploration activities are its interest in mining, exploration and prospecting diamond licenses in Lesotho, Botswana and Namibia. The Company�� project Mothae Diamond Project is located in northeast Lesotho. In May 2010, it commenced test mining in Mothae Diamond Project-Lesotho. Mothae Diamonds (PTY) Ltd (Mothae Diamonds), an indirect 75% owned subsidiary of the Company, holds a 100% interest in the Mothae project. As of March 23, 2011, a total of 175,000 dry tons had been processed from the C domain, producing 5,484 carats at an average grade of 3.13 carats per hundred tons. In December 2010, the Company completed the acquisition of African Diamonds PLC, upon which Lucara indirectly owns 100% of the AK6 Diamond Project. Advisors' Opinion:- [By John Leonard]
Lucara Diamond (LUCRF.PK) is still being valued as a riskier exploration stage miner rather than a profitable and growing producer. The current "backward looking" valuation fails to reflect the recent and significant operational transition.
Top Supermarket Stocks To Watch Right Now: Pozen Inc.(POZN)
POZEN Inc., a pharmaceutical company, develops products for the treatment of acute and chronic pain, and other pain-related conditions in the United States. Its products include Treximet for acute treatment of migraine attacks with or without aura in adults; and VIMOVO for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as to decrease the risk of developing gastric ulcers in patients at risk of developing non-steroidal anti-inflammatory drugs (NSAID)-associated gastric ulcers. The company also develops PA32540, a product candidate, which is under 2 pivotal Phase 3 trials for the secondary prevention of cardiovascular disease in patients at risk for gastric ulcers. It has collaborations with GlaxoSmithKline for the development and commercialization of proprietary combinations of a triptan and a long-acting NSAID; and with AstraZeneca AB for the development and commercialization of proprietary fixed dose combi nations of the proton pump inhibitor esomeprazole magnesium with the NSAID naproxen. The company was founded in 1996 and is headquartered in Chapel Hill, North Carolina.
Advisors' Opinion:- [By Garrett Cook]
Healthcare shares dropped by 0.34 percent in the US market on Wednesday. Top losers in the sector included POZEN (NASDAQ: POZN), down 7.2 percent, and Ligand Pharmaceuticals (NASDAQ: LGND), off 5.5 percent.
- [By James E. Brumley]
At first glance, POZEN Inc. (NASDAQ:POZN) doesn't look like anything more than a volatile mover and shaker, currently overbought, and due for a dip. And truth be told, POZN is overbought and due for a pullback (and will be even more so, given this morning's bullish pre-market activity). When you take a step back and look at the much-bigger-picture though, you'll find that POZEN Inc. is only at the beginning of what could be a sizeable move for investors willing to give it some time.
- [By Monica Gerson]
POZEN (NASDAQ: POZN) shares fell 18.96% to $7.82 in the pre-market trading. POZEN's trailing-twelve-month ROE is -25.44%.
The Walt Disney Company (NYSE: DIS) dipped 1.63% to $74.99 in the pre-market session. Disney's trailing-twelve-month profit margin is 13.62%.
- [By Garrett Cook]
Healthcare shares dropped by 0.34 percent in the US market on Wednesday. Top losers in the sector included POZEN (NASDAQ: POZN), down 7.57 percent, and Ligand Pharmaceuticals (NASDAQ: LGND), off 6.77 percent.
Top Supermarket Stocks To Watch Right Now: WisdomTree SmallCap Dividend Fund (DES)
WisdomTree SmallCap Dividend Fund (the Fund) seeks investment results that closely correspond to the price and yield performance of the WisdomTree SmallCap Dividend Index (the Index). The Index is a fundamentally weighted index measuring the performance of the small-capitalization segment of the United States dividend-paying market. The Index consists of the companies that compose the bottom 25% of the market capitalization of the WisdomTree Dividend Index after the 300 largest companies have been removed.
The Index is dividend weighted annually to reflect the proportionate share of the aggregate cash dividends each component company is projected to pay in the coming year, based on the most recently declared dividend per share. The Fund�� investment advisor is WisdomTree Asset Management, Inc., a wholly owned subsidiary of WisdomTree Investments, Inc.
Advisors' Opinion:- [By Philip Springer]
WisdomTree SmallCap Dividend ETF (DES) invests in dividend-paying small-cap companies that meet certain liquidity requirements. It then weights them by the dollar value of dividends they are expected to pay out over the next year.
- [By Selena Maranjian]
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some small dividend-paying stocks to your portfolio but don't have the time or expertise to hand-pick a few, the WisdomTree SmallCap Dividend ETF (NYSEMKT: DES ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.
The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The WisdomTree ETF's expense ratio -- its annual fee -- is a rather low 0.38%. It recently yielded more than 3%.
This ETF has performed well, beating the S&P 500 over the past three and five years. As with most investments, of course, we can't expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.
Top Supermarket Stocks To Watch Right Now: Hospira Inc (HSP)
Hospira, Inc. (Hospira), incorporated on September 16, 2003, is a provider of injectable drugs and infusion technologies. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira's portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira conducts operations worldwide and is managed in three reportable segments: Americas; Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment includes the United States, Canada and Latin America; the EMEA segment includes Europe, the Middle East and Africa, and the APAC segment includes Asia, Japan, Australia and New Zealand. In all segments, Hospira sells a line of products, including specialty injectable and other pharmaceuticals and medication management products.
Specialty Injectable Pharmaceuticals
Hospira's specialty injectable pharmaceutical products consist of generic injectable pharmaceuticals. The other drugs' therapeutic areas include analgesia, anesthesia, anti-infectives, cardiovascular, oncology, and other areas. All of Hospira's generic injectable pharmaceuticals in the United States include unit-of-use bar-code labels that can be used to support medication delivery. Hospira primarily procures the active pharmaceutical ingredients in these products from third-party suppliers. During the year ended December 31, 2011, Hospira portfolio included 87 injectable drug launches consisting of 13 compounds. Among these launches included, in the United States, docetaxel (an oncolytic drug used to treat a variety of cancers), topotecan (an oncolytic drug used for the treatment of small cell lung cancer) and imipenem-cilastatin (a beta-lactam antibiotic). Hospira also launched a solution formulation of gemcitabine (an oncolytic drug used to treat a variety of cancers), which augmented Hospira's portfolio of gemcitabin! e products. New-to-country launches in EMEA in 2011, included topotecan, meropenem, gemcitabine, imipenem-cilastatin, remifentanil, docetaxel and levofloxacin. New-to-country launches in APAC in 2011, included docetaxel, piperacillin tazobactam, oxaliplatin, meropenem and gemcitabine. Hospira's specialty injectable pharmaceutical products also include Precedex (dexmedetomidine HCl), a sedative. Precedex is licensed to Hospira by Orion Corporation in the Americas and APAC segments, and in the Middle East and Africa.
Hospira sells and markets Precedex for use in non-intubated patients requiring sedation, as well as intubated and mechanically ventilated patients. Hospira's specialty injectable pharmaceuticals also include biologic products, which are molecules derived from cells that are demonstrated to be similar to an approved originator product. Hospira's biosimilar, Retacrit, was available in 20 EMEA countries during 2011. Its second biosimilar, Nivestim, was launched during the year ended December 31, 2010, and was available in 21 countries, including Australia, where the biosimilar filgrastim product was launched in 2011. Hospira's drug delivery formats include offerings in ampules and flip-top vials, which clinicians can use with standard syringes. Hospira's drug delivery options include Carpuject and iSecure prefilled syringes, AnsyrTM prefilled needleless emergency syringe systems, First Choice ready-to-use premix and the ADD-Vantage system for preparing drug solutions from prepackaged drug powders or concentrates.
Other Pharmaceuticals
Hospira's other pharmaceuticals primarily consist of intravenous (I.V.) solutions, nutritionals and contract manufacturing services. Hospira offers infusion therapy solutions and related supplies that include I.V. solutions for general use, I.V. nutrition products, and solutions for the washing and cleansing of wounds or surgical sites. All of Hospira's injectable I.V. solutions in the United States include unit-of-use bar-c! ode label! s that can be used to support medication management efforts. Hospira also offers infusion therapy solutions in its VisIV non-PVC, non-DEHP I.V. container, an I.V. bag. Hospira's contract manufacturing services are offered through its One2One services group, which provides formulation development, filling and finishing of injectable and oral drugs worldwide. Hospira works with its pharmaceutical and biotechnology customers to develop injectable forms of their drugs, and Hospira fills and finishes those and other drugs into containers and packaging selected by the customer. The customer then sells the finished products under its own label. Hospira's One2One manufacturing services group generally does not manufacture active pharmaceutical ingredients, but offers a range of filling and finishing services in a variety of delivery systems.
Medication Management
Medication management products include electronic drug delivery pumps, safety software and disposable administration sets dedicated to Hospira pumps. These sets are used to deliver I.V. fluids and medications. Hospira also offers software maintenance agreements and other service offerings. Hospira's electronic drug delivery pumps include Hospira's general infusion system, Symbiq; the Plum A+ line of infusion pumps; Hospira's patient-controlled analgesia device, LifeCare PCA; the GemStar ambulatory infusion pump; and the Plum XLD infusion pump. Hospira offers the Hospira MedNet safety software system, which has been designed to enable hospitals to customize intravenous drug dosage limits and track drug delivery to prevent medication errors. The wireless network version of the Hospira MedNet system establishes real-time send-and-receive capability and can interface with select hospital and pharmacy information systems. The Hospira MedNet system is standard in the Symbiq infusion system, and is also available as an additional feature for the Plum A+ line, and LifeCare PCA devices. Hospira also offers safety software with its Ge! mStar pum! p.
Medication management includes TheraDoc, Inc. products, which are module-based clinical surveillance systems that provide patient safety surveillance and clinical decision support. Medication management also includes gravity administration sets and other device products, including needlestick safety products and programs to support Hospira's customers' needlestick prevention initiatives. LifeShield CLAVE and LifeShield MicroCLAVE connectors are one-piece valves that directly connect syringes filled with medications to a patient's I.V. line without the use of needles. ICU Medical's CLAVE connectors are a component of administration sets sold by Hospira to its customers in the United States and select markets outside the United States.
The Company competes with Baxter International Inc., Boehringer Ingelheim, Fresenius Kabi, Pfizer, Sandoz, Sanofi, Teva Pharmaceuticals, B. Braun Melsungen AG, CareFusion, Terumo, Actavis, Intas Pharmaceuticals, Ltd, Medac GmbH, Mylan Inc., Sun Pharmaceutical Industries, Ltd. and Aspen.
Advisors' Opinion:- [By Dimitra DeFotis]
Among pharma names that moved higher,�Regeneron Pharmaceuticals (REGN) rallied nearly 6% and Hospira (HSP) jumped more than 8%. And healthcare was otherwise in the headlines. Genworth Financial (GNW) was among the day’s worst performers, down 14%. Insurer Genworth likely faces higher reserves for long-term care payouts.
Top Supermarket Stocks To Watch Right Now: Optical Cable Corporation (OCC)
Optical Cable Corporation designs, manufactures, markets, and sells fiber optic, and copper data communications cabling and connectivity solutions primarily for the enterprise market in the United States and internationally. The company offers fiber optic cables for military field applications, and indoor and outdoor use; and copper datacom cables, including unshielded and shielded twisted pair for copper network installations. It also provides fiber optic connectivity products, such as fiber optic wall mounts, cabinet mounts and rack mount enclosures, pre-terminated fiber optic enclosures, fiber optic connectors, splice trays, fiber optic jumpers, plug and play cassette modules, pre-terminated fiber optic cable assemblies, adapters, and accessories; and copper connectivity products, including category compliant patch panels, jacks, plugs, patch cords, faceplates, surface mounted boxes, distribution and multi-media boxes, copper rack mount and wall mount enclosures, cable assemblies, cable organizers, and other wiring products for datacenter, telecommunications closet, equipment room, and workstation applications. In addition, the company offers data cabinets, wall-mount enclosures, cable management systems, and open frame relay racks for commercial and residential use; various enclosures, modules, and modular outlets for single dwelling and multiple dwelling residential uses; and cellular distribution system, a distributed antenna system for in-building enhancement of wireless communications signals. Further, it provides applied interconnect systems, such as specialty fiber optic connectors and connectivity components, ruggedized copper datacom connectors, and related systems and solutions for military and harsh environment applications. The company sells its products to distributors, original equipment manufacturers, value-added resellers, and end-users. Optical Cable Corporation was founded in 1983 and is headquartered in Roanoke, Virginia .
Advisors' Opinion:- [By Ning Jia]
First Security entered into a Consent Order with the Bank's primary regulator, the Office of the Comptroller of the Currency (OCC) during April 2010 and a Written Agreement with the Federal Reserve Bank during September 2010.
No comments:
Post a Comment